Expert Edge: A View from ARUP’s Medical Directors

Our pathology experts offer insight into leading-edge technology and tests in the Expert Edge, a new Q & A series ARUP is placing in CAP Today. Nationally and internationally respected for their expertise, these specialists have made significant contributions in research and development, and serve as faculty at the University of Utah School of Medicine.

Expert Edge

Previous Editions

Why Establish Pediatric Reference Intervals?
Joely Straseski, PhD, DABCC, Medical Director, Endocrinology, Co-Medical Director, Core Laboratory

Understanding Thiopurine Drug Toxicity Testing
Kamisha Johnson-Davis, PhD, DABCC (CC, TC), Medical Director, Clinical Toxicology

Myositis Testing: Homing in on Culprit Autoantibodies
Anne Tebo, PhD, Medical Director, Immunology

The Challenges and Advancements in Newborn Drug-Exposure Testing
Gwendolyn McMillin, PhD, Medical Director, Toxicology and Pharmacogenetics

Heads in the Cloud: Harnessing the Healing Power of Bioinformatics
Frederick Strathmann, PhD, Acting Scientific Director, BioComputing
Elaine Gee, PhD, Director, Bioinformatics

How Are Genetic Counselors Strengthening Lab Utilization Management?
Sara Brown, MS, LCGC, Genetic Counselor

Advancing NGSBased, Pathogen-Detection Testing
Robert Schlaberg, MD, Dr. Med, MPH, Medical Director, Microbial Amplified Detection, Virology and Fecal Chemistry, Assistant Medical Director, Molecular Infectious Disease

Heparin-Induced Thrombocytopenia: Is SRA the Gold Standard Test?
Kristi J. Smock, MD, Medical Director, Hemostasis & Thrombosis Laboratory

Improving Diagnostics for Detecting GI Pathogens
Marc Roger Couturier, PhD, D(ABMM), Medical Director, Microbial Immunology, Parasitology, and Infectious Disease Rapid Testing

Breakthrough Technology Spurs New Test: for Non-Small Cell Lung Cancer Patients
Wade Samowitz, MD, Medical Director, Solid Tumor Molecular Diagnostics and Histology, Staff Pathologist, Anatomic Pathology

Revolutionizing Treatment for Cancer Care: New Circulating Cell-Free Tumor DNA (ctDNA) Technology
Mary Bronner, MD, Division Chief, Anatomic Pathology and Oncology

Digital Pathology: Transforming Pathology from a Qualitative to a Quantitative Science
Mohamed E. Salama, MD, Medical Director, Hematopathology and Immunohistochemistry Staining